HemaSphere (May 2023)
B05 PLASMA CELL LEUKEMIA-LIKE STATUS HAS INDEPENDENT PROGNOSTIC VALUE IN THE CONTEXT OF THE SECOND REVISION OF THE INTERNATIONAL STAGING SYSTEM
- D. Hofste op Bruinink,
- R. Kuiper,
- M. van Duin,
- T. Cupedo,
- V. van der Velden,
- R. Hoogenboezem,
- B. van der Holt,
- B. Beverloo,
- E. Valent,
- M. Vermeulen,
- M. D’Agostino,
- F. Gay,
- A. Broijl,
- H. Avet-Loiseau,
- N. Munshi,
- P. Musto,
- P. Moreau,
- S. Zweegman,
- N. van de Donk,
- P. Sonneveld
Affiliations
- D. Hofste op Bruinink
- 1 Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands
- R. Kuiper
- 1 Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands
- M. van Duin
- 1 Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands
- T. Cupedo
- 1 Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands
- V. van der Velden
- 2 Department of Immunology, Erasmus University Medical Center, Rotterdam, the Netherlands
- R. Hoogenboezem
- 1 Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands
- B. van der Holt
- 4 HOVON Data Center, Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands
- B. Beverloo
- 5 Department of Clinical Genetics, Erasmus University Medical Center, Rotterdam, the Netherlands
- E. Valent
- 3 SkylineDx, Rotterdam, the Netherlands
- M. Vermeulen
- 1 Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands
- M. D’Agostino
- 6 Myeloma Unit, Division of Hematology, University of Torino, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino, Torino, Italy
- F. Gay
- 6 Myeloma Unit, Division of Hematology, University of Torino, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino, Torino, Italy
- A. Broijl
- 1 Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands
- H. Avet-Loiseau
- 7 Unité de Génomique du Myélome, IUC-Oncopole, Toulouse, France
- N. Munshi
- 8 Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA
- P. Musto
- 9 “Aldo Moro” University School of Medicine, Unit of Hematology and Stem Cell Transplantation, AOUC Policlinico, Bari, Italy
- P. Moreau
- 10 Hematology Department, University Hospital Hôtel-Dieu, Nantes, France
- S. Zweegman
- 11 Department of Hematology, Amsterdam UMC, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, the Netherlands
- N. van de Donk
- 11 Department of Hematology, Amsterdam UMC, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, the Netherlands
- P. Sonneveld
- 1 Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands
- DOI
- https://doi.org/10.1097/01.HS9.0000936112.95843.f3
- Journal volume & issue
-
Vol. 7,
no. S2
pp. 6 – 6
Abstract
No abstracts available.